TOGAR
Phase 2 Terminated
3 enrolled
Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.
Phase 2/3 Terminated
18 enrolled
FOLFIRINOX + NIS793 in Pancreatic Cancer
Phase 1 Terminated
4 enrolled
DisTinGuish
Phase 2 Terminated
247 enrolled 38 charts
COCHISE
Phase 2 Terminated
18 enrolled 9 charts
FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer
Phase 2 Terminated
11 enrolled
Lithium
Phase 1 Terminated
2 enrolled
NeoRacing
Phase 2 Terminated
6 enrolled
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
Phase 1 Terminated
221 enrolled
Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Phase 1/2 Terminated
178 enrolled 33 charts
PIOPPO
Phase 2 Terminated
30 enrolled
CLavSyn
Phase 2 Terminated
54 enrolled
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer
Phase 3 Terminated
340 enrolled
A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer
Phase 2 Terminated
8 enrolled 11 charts
QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Phase 1/2 Terminated
6 enrolled 15 charts
QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
Phase 1/2 Terminated
2 enrolled 13 charts
RESCUE-GC
Phase 3 Terminated
29 enrolled
MODULATE
Phase 1/2 Terminated
2 enrolled 7 charts
A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ)
Phase 2 Terminated
29 enrolled
PECORINO
Phase 2 Terminated
69 enrolled
QUILT-3.080: NANT Pancreatic Cancer Vaccine
Phase 1/2 Terminated
3 enrolled 13 charts
Trial of Tolcapone With Oxaliplatin for Neuroblastoma
Phase 1 Terminated
5 enrolled
HIGH-LIGHT
Phase 2 Terminated
21 enrolled 12 charts
QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Phase 1/2 Terminated
3 enrolled 9 charts
Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer
Phase 1 Terminated
3 enrolled 9 charts
QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Phase 1/2 Terminated
4 enrolled 9 charts
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
Phase 1 Terminated
2 enrolled
Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM
Phase 3 Terminated
92 enrolled
Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer
Phase 2 Terminated
23 enrolled 14 charts
Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer
Phase 2 Terminated
11 enrolled 11 charts
Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer
Phase 2 Terminated
17 enrolled 9 charts
A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer
Phase 2 Terminated
4 enrolled 9 charts
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
Phase 3 Terminated
355 enrolled 11 charts
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
Phase 2 Terminated
22 enrolled 5 charts
Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors
Phase 2/3 Terminated
36 enrolled 14 charts
FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM
Phase 3 Terminated
92 enrolled
SOHUG
Phase 2 Terminated
8 enrolled
Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma
Phase 2 Terminated
9 enrolled 14 charts
repeat
Phase 2 Terminated
15 enrolled
ARGO
Phase 2 Terminated
53 enrolled
PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma
Phase 2 Terminated
8 enrolled 9 charts
Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma
Phase 1 Terminated
27 enrolled
PIPOX
Phase 1/2 Terminated
34 enrolled
SENTINEL
Phase 1 Terminated
10 enrolled 13 charts
BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer
Phase 1 Terminated
25 enrolled 9 charts
Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab
Phase 2 Terminated
23 enrolled 8 charts
Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004
Phase 2 Terminated
30 enrolled 15 charts
GCC 1314
Phase 2 Terminated
3 enrolled 8 charts
Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
Phase 2 Terminated
7 enrolled 5 charts
IPOX-FOLFIRI
Phase 1 Terminated
1 enrolled